Inflammation of the brain during AD pathogenesis results in ROS generation by glial cells, leading to the recruitment of PON-3 for its antioxidant function in decreasing ROS levels and reducing lipid peroxidation [17]. Here, PON3 is linked to Alzheimer disease.